FDA Drug Safety Communication: Updated recommendations to decrease risk of spinal column bleeding and paralysis in patients on low molecular weight heparins

<!–

–>

<!–

• Page Last Updated: 11/06/2013

–>
Page Last Updated: 11/06/2013
<!–

–>

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.